ArticleTargeted oncology2025

Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform Neurofibromas.

Xiaojie Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.